Loghman Pharmaceuticals
Iranian pharmaceutical company
- Medical equipment
- Pharmaceutical
Area served
Key people
chief executive officer Alireza Zohrevand,
Chairman
Ampoule, Tablet (pharmacy), Capsule (pharmacy)
Net income
44 Billion IRR (2009) 437 Billion IRR (2009)Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان, Shirkat-e Darvii-ye vâ Behedashiti-ye Laqman) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of drugs in Iran.[1]
History
Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.[2]
The company has been listed on the Tehran Stock Exchange since 1997.[3]
products
- Acetaminophen+Codeine
- Amoxicillin
- Azithromycin
- Buspirone
- Carbamazepine
- Cefalexin
- Cefazolin
- Cefepime
- Cefixime
- Ceftazidime
- Ceftriaxone
- Cefuroxime
- Cefalexin
- Diazepam
- Erythromycin
- Fluconazole
- Sodium Fluoride
- Ibuprofen
- Indomethacin
- Lorazepam
- Losartan Potassium
- Meropenem
- Methimazole
- Nortriptyline
- Phenytoin
- Sodium Fluoride
- Sorbitol
- Valsartan
Development plan
See also
References
- v
- t
- e
Companies listed on the Tehran Stock Exchange- Aabsal
- Arya Sasol
- AzarAb Industries
- Bahman Group
- Bank Mellat
- Bank Pasargad
- Bank Saderat
- Behran Oil
- Chadormalu Mining
- Darou Pakhsh
- Data Processing Iran
- EN Bank
- Ghadir Investment
- HEPCO
- KSC
- Iran Combine Manufacturing
- Iran Khodro
- Iran Tractor Manufacturing
- Iranian Aluminium
- Jaber Ebne Hayyan Pharmaceutical
- Jam petrochemical company
- Jey Oil Refining Company
- Karafarin Bank
- Loghman Pharmaceuticals
- Machine Sazi Arak
- MAPNA
- MCI
- Mobarakeh Steel
- Navard Aluminium
- North Drilling
- Offset Press
- Pars Khodro
- Pars Oil
- Parsian Bank
- SADRA
- SAIPA
- Sepahan Oil Company
- Sina Bank
- Tejarat Bank
- TCI
- Tidewater Middle East
- Tolypers
 | This Iran-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
